Find information on how we’re keeping you safe from COVID-19 here

To top

Areas of Expertise

Professor Richard Pollok performs a range of treatments, including:

Some of the conditions she commonly treats are:

  • Inflammatory Bowel Disease
  • Irritable bowel syndrome
  • Colonoscopy
  • Gastrointestinal Infection
  • Crohn’s disease
  • Ulcerative colitis,
  • Irritable bowel syndrome,
  • Colonic polyps
  • Bowel cancer
  • Stomach Cancer
  • Peptic Ulcers

Career Highlights

Professor Richard Pollok (FRCP, PhD, BSc, DTM&H) 

Prof Pollok is always kind and listens to me…. he really put me at ease when I had my colonoscopy…

Research and Press highlights

Key Publications

Blackwell J et al. Depression in individuals who subsequently develop Inflammatory Bowel Disease: a population-based nested case-control study Gut 2020 October e-pub

Backwell J et al. Prevalence and duration of symptoms before diagnosis of Inflammatory bowel disease and predictors of timely referral: a population based study. J Crohns Colitis 2020 Jul 15:jjaa146. Doi 10.1093/ecco-jcc/jjaa146

Din S, Kent A, Pollok R et al, Management of acute severe ulcerative colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel, Gut 2020 Oct;69(10):1769-1777

Kennedy NA, Jones GR, Lamb CA et al, British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut. 2020 Jun;69(6):984-990. doi: 10.1136/gutjnl-2020-321244.

HALT-IT Trial Collaborators, Tranexamic acid for the treatment of gastrointestinal bleeding: an international, randomised, double blind controlled trial. Lancet, 2020 Jun 20;395(10241):1927-1936

 

●Selinger CP, Parkes GC, Bassi A et al, Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients. Aliment Pharmacol Ther. 2019 Nov;50(9):1009-1018. doi: 10.1111/apt.15497

Blackwell J, Saxena S, Alexakis C et al, The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population-based study. Aliment Pharmacol Ther. 2019 Sep;50(5):556-567. doi: 10.1111/apt.15390

Walker GJ, Harrison JW, Heap GA et al, Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.JAMA. 2019 Feb 26;321(8):773-785. doi: 10.1001/jama.2019.0709

Alexakis C, Saxena S, Chhaya V. Smoking Status at Diagnosis and Subsequent Smoking Cessation: Associations with Corticosteroid Use and Intestinal Resection in Crohn’s Disease. Am J Gastroenterol. 2018 Nov;113(11):1689-1700. doi: 10.1038/s41395-018-0273-7

Taylor SA, Mallett S, Bhatnagar G. Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn’s disease (METRIC): a multicentre trial.Lancet Gastroenterol Hepatol. 2018 Aug;3(8):548-558. doi: 10.1016/S2468-1253(18)30161

Get to know Professor Richard Pollok…

Professor Richard Pollok
  • Why did you choose to be part of the OneWelbeck team?

    A high quality team running a top-draw service

  • What are the moments which stand out most in your career so far?

    • Promotion to Professor of Gastroenterology
    • Recent publication in the Lancet and the  journal Gut
    • Winning a Wellcome Trust Research Fellowship
    • Winning a national research prize
  • What keeps you busy in your personal life?

    Sailing, Ceramics and Oenology

Do you want to enquire or book an appointment?